8LBA - LATE-BREAKING ABSTRACT: Two year overall survival rate of all advanced melanoma patients treated with ipilimumab in Australia 2013-2014

H. Kim; S. Comey

doi:10.1016/s0959-8049(17)30501-4

8LBA - LATE-BREAKING ABSTRACT: Two year overall survival rate of all advanced melanoma patients treated with ipilimumab in Australia 2013-2014

H. Kim
, S. Comey

Faculty of Health Sciences & Medicine

Research output: Contribution to journal › Meeting Abstract › Research

Original language	English
Pages (from-to)	S129-S129
Number of pages	1
Journal	European Journal of Cancer
Volume	72
Issue number	Supplement 1
DOIs	https://doi.org/10.1016/s0959-8049(17)30501-4
Publication status	Published - Feb 2017
Event	ECCO: 2017 European Cancer Congress - Amsterdam, Netherlands Duration: 27 Jan 2017 → 30 Jan 2017 https://www.eacr.org/meeting/ecco2017-european-cancer-congress

Access to Document

10.1016/s0959-8049(17)30501-4

Cite this

@article{6c157473da8440eeb90ede76bd43fcb7,

title = "8LBA - LATE-BREAKING ABSTRACT: Two year overall survival rate of all advanced melanoma patients treated with ipilimumab in Australia 2013-2014",

author = "H. Kim and S. Comey",

year = "2017",

month = feb,

doi = "10.1016/s0959-8049(17)30501-4",

language = "English",

volume = "72",

pages = "S129--S129",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier",

number = "Supplement 1",

note = "ECCO: 2017 European Cancer Congress ; Conference date: 27-01-2017 Through 30-01-2017",

url = "https://www.eacr.org/meeting/ecco2017-european-cancer-congress",

}

TY - JOUR

T1 - 8LBA - LATE-BREAKING ABSTRACT: Two year overall survival rate of all advanced melanoma patients treated with ipilimumab in Australia 2013-2014

AU - Kim, H.

AU - Comey, S.

PY - 2017/2

Y1 - 2017/2

U2 - 10.1016/s0959-8049(17)30501-4

DO - 10.1016/s0959-8049(17)30501-4

M3 - Meeting Abstract

SN - 0959-8049

VL - 72

SP - S129-S129

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - Supplement 1

T2 - ECCO: 2017 European Cancer Congress

Y2 - 27 January 2017 through 30 January 2017

ER -